- Published at
- by benzinga.com
positive
positive
Codiak Announces Closing of $66.4 Million Public Offering, Including Full Exercise of Underwriters' Option
CAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK) ("Codiak"), a clinical-stage biopharmaceutical company focused on ...